Speakers

  • Diego Ardigò, Chiesi Farmeceutici S.p.A., Italy
  • Christopher Austin, National Center for Advancing Translational Sciences (NCATS), Bethesda, USA
  • Gareth Baynam, Genetic Services of Western Australia, Perth, Australia
  • Claudio Bordignon, MolMed S.p.A., Milan, Italy
  • Kym Boycott, Children’s Hospital Eastern Ontario, Ottawa, Canada
  • Anna Bucsics, University of Vienna, Vienna, Austria
  • Jodi Cook, Agilis Biotherapeutics LLC, Cambridge, USA
  • Hugh Dawkins, Western Australian Department of Health, Perth, Australia
  • Ruxandra Draghia-Akli, European Commission – DG Research and Innovation (DG RTD), Brussels, Belgium
  • Hawa Dramé, Fondation Internationale Tierno et Mariam (FITIMA), Burkina Faso
  • Christopher Gibson, Recursion Pharmaceuticals Inc., Salt Lake City, USA
  • Jonathan Goldsmith, US Food and Drug Administration (FDA), Silver Spring, USA
  • Ivo Gut, Centro Nacional de Análisis Genómico (CNAG), Spain
  • Melissa Haendel, Monarch Initiative and Oregon Health & Science University, Portland, USA
  • Caroline Hager, European Commission – DG Health and Food Safety (DG SANTÉ), Brussels, Belgium
  • Ada Hamosh, John Hopkins University School of Medicine, Baltimore, USA
  • Mats Hansson, Uppsala University, Sweden
  • Robert Hufnagel, National Eye Institute (NEI), Bethesda, USA
  • Stuart Hughes, Vertex Pharmaceuticals, Oxford, UK
  • Alain Huriez, Advent Life Sciences, Paris, France
  • Carlo Incerti, Genzyme Europe, Modena, Italy
  • Edmund Jessop, National Health Service (NHS) England, London, UK
  • Sangeeta Jethwa, Roche Innovation Centre, Basel, Switzerland
  • Petra Kaufmann, National Center for Advancing Translational Sciences (NCATS) and Office of Rare Diseases (ORDR), Bethesda, USA
  • Stephen Kingsmore, Rady Children’s San Diego, San Diego, USA
  • Hideyuki Kondo, Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo, Japan
  • Matthias Kretzler, EURenOmics and University of Michigan, Ann Arbor, USA
  • Anders Larsson, Uppsala University, Uppsala, Sweden
  • Kristina Larsson, European Medicines Agency (EMA), London, UK
  • Paul Lasko, Canadian Institutes for Health Research, Montreal, Canada
  • Yann Le Cam, EURORDIS, Paris, France
  • Hanns Lochmüller, Newcastle University, Newcastle upon Tyne, UK
  • Milan Macek, Charles University, Prague, Czech Republic
  • Romain Marignier, CHU de Lyon, Lyon, France
  • Marc Martinell, Minoryx, Barcelona, Spain
  • Matt Might, University of Utah, Utah, USA
  • Federico Mingozzi, Genethon, Paris, France
  • Eric Minikel, Broad Institute, Cambridge, USA
  • Sophie Nicole, Université Pierre et Marie Curie, Paris, France
  • Yukiko Nishimura, ASrid, Tokyo, Japan
  • Ichizo Nishino, MD, PhD, Director, Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Japan
  • Irene Norstedt, European Commission – DG Research and Innovation (DG RTD), Brussels, Belgium
  • Anders Olauson, Ågrenska Foundation, Hovas, Sweden
  • Graziella Pellegrini, University of Modena and Reggio Emilia, Modena, Italy
  • Slavé Petrovski, University of Melbourne, Australia
  • Kiran Reddy, Clarus Ventures, Boston, USA
  • Makoto Suematsu, Japan Agency for Medical Research and Development (AMED), Tokyo, Japan
  • Toshiki Takenouchi, Keio University, Tokyo, Japan
  • Sonia Vallabh, Broad Institute, Cambridge, USA
  • David Valle, John Hopkins University School of Medicine, Baltimore, USA
  • Edward Visser, Erasmus Medical Center, The Netherlands
  • Nan Wu, Peking Union Medical College Hospital, Beijing, China